UV Germi SA (EPA:ALUVI)

UV Germi Statistics

Total Valuation

UV Germi has a market cap or net worth of EUR 9.13 million. The enterprise value is 4.46 million.

Market Cap	9.13M
Enterprise Value	4.46M

Important Dates

The next estimated earnings date is Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	n/a

Share Statistics

UV Germi has 3.18 million shares outstanding.

Current Share Class	3.18M
Shares Outstanding	3.18M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.99%
Owned by Institutions (%)	n/a
Float	1.39M

Valuation Ratios

The trailing PE ratio is 12.86.

PE Ratio	12.86
Forward PE	n/a
PS Ratio	1.03
PB Ratio	0.92
P/TBV Ratio	1.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	6.28
EV / Sales	0.50
EV / EBITDA	5.20
EV / EBIT	8.89
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.03, with a Debt / Equity ratio of 0.01.

Current Ratio	8.03
Quick Ratio	5.67
Debt / Equity	0.01
Debt / EBITDA	0.11
Debt / FCF	n/a
Interest Coverage	410.37

Financial Efficiency

Return on equity (ROE) is 7.48% and return on invested capital (ROIC) is 3.26%.

Return on Equity (ROE)	7.48%
Return on Assets (ROA)	2.92%
Return on Invested Capital (ROIC)	3.26%
Return on Capital Employed (ROCE)	5.06%
Weighted Average Cost of Capital (WACC)	3.08%
Revenue Per Employee	201,709
Profits Per Employee	16,135
Employee Count	44
Asset Turnover	0.83
Inventory Turnover	1.72

Taxes

Income Tax	-138,122
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.52% in the last 52 weeks. The beta is -0.21, so UV Germi's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	+5.52%
50-Day Moving Average	2.91
200-Day Moving Average	2.65
Relative Strength Index (RSI)	46.62
Average Volume (20 Days)	2,595

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, UV Germi had revenue of EUR 8.88 million and earned 709,927 in profits. Earnings per share was 0.22.

Revenue	8.88M
Gross Profit	4.01M
Operating Income	501,474
Pretax Income	571,805
Net Income	709,927
EBITDA	857,977
EBIT	501,474
Earnings Per Share (EPS)	0.22

Balance Sheet

The company has 4.76 million in cash and 91,992 in debt, with a net cash position of 4.67 million or 1.47 per share.

Cash & Cash Equivalents	4.76M
Total Debt	91,992
Net Cash	4.67M
Net Cash Per Share	1.47
Equity (Book Value)	9.88M
Book Value Per Share	3.11
Working Capital	8.05M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 45.21%, with operating and profit margins of 5.65% and 8.00%.

Gross Margin	45.21%
Operating Margin	5.65%
Pretax Margin	6.44%
Profit Margin	8.00%
EBITDA Margin	9.67%
EBIT Margin	5.65%
FCF Margin	n/a

Dividends & Yields

UV Germi does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	7.78%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

UV Germi has an Altman Z-Score of 7.09 and a Piotroski F-Score of 6.

Altman Z-Score	7.09
Piotroski F-Score	6